David Young - Oct 12, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Pres. Research & Development, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Oct 12, 2023
Transactions value $
$45,030
Form type
4
Date filed
10/12/2023, 05:54 PM
Previous filing
Oct 10, 2023
Next filing
Apr 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $45K +155K +25.35% $0.29 768K Oct 12, 2023 Direct
holding PCSA Common Stock 620K Oct 12, 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 216K Oct 12, 2023 By Family Entities
holding PCSA Common Stock 371K Oct 12, 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.